Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Rosario Vasta, MD, University of Turin, Turin, Italy, outlines a new probabilistic model of disease progression that predicts functional impairment and survival in amyotrophic lateral sclerosis (ALS) patients. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.